Bristol-Myers Says Celgene Deal On Track For Q3 Close After Shareholder Approval By: TalkMarkets April 12, 2019 at 14:40 PM EDT More than 75% of the shares voted at the special meeting were voted in favor of the Celgene merger agreement. Read More >> Related Stocks: Bristol-Myers Squibb Celgene Corp